This creates a personalized playbook you can reference when cravings returnyou'll have concrete proof of what worked rather than relying on memory
J Obes Metab Syndr 32(1):2545 Tian S, Zhou S, Wu W, lin Y, Wang T, Sun H, et al (2025) GLP-1 Receptor agonists alleviate diabetic kidney injury via -klotho-mediated ferroptosis inhibition
They increase insulin production, reduce appetite, and slow gastric emptying, making them effective for managing type 2 diabetes and aiding weight management
When GLP-1 binds to its receptor, it amplifies the insulin signaling pathway, causing increased phosphorylation of insulin receptor substrates and activating the PI3K/Akt pathway, which ultimately results in enhanced glucose uptake, utilization within the liver, and reduced production of glucose (gluconeogenesis)